Latest filing published 11 Jun 2020 for DNA X, Inc., €9,927.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -30.2%Entry US$1,603.80 · Close at T+365 US$1,119.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Maurice Hochschild: trading record in brief
All filings by Maurice Hochschild on record concern DNA X, Inc. In total, 3 filings cover trades dated from 13 November 2019 to 9 June 2020.
No open-market sale appears; the market trades are 1 purchase worth €9,927. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants. Since January 2020: 1 purchase and no sales on the market.
The latest filing, published on 11 June 2020, reports an open-market purchase of €9,927 in DNA X, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Maurice Hochschild
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ US$0.75100.0% of flowCommon StockSEC:0001209191-20-036001:1Canonical exit: 7 Sept 2020 (T+90)
- 104,000 shares0Common StockSEC:0001209191-20-036001:0
- 15,000 shares0Common StockSEC:0001209191-19-056813:0
3 of 3 declarations